Preclinical Risk Evaluation of Normal Tissue Injury With Novel Radiosensitizers
Authors:
- 1 December 2021
- journal article
- review article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 111 (5) , e54-e62
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- α-Tocopherol Succinate Protects Mice against Radiation-Induced Gastrointestinal InjuryRadiation Research, 2012
- Use of Normal Tissue Complication Probability Models in the ClinicInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Radiation Dose–Volume Effects in the BrainInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- What Is the Optimal Value of the g-Ratio for Myelinated Fibers in the Rat CNS? A Theoretical ApproachPLOS ONE, 2009
- Clinical Radiation Sensitivity With DNA Repair Disorders: An OverviewInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Normal Tissue Tolerance Dose Metrics for Radiation Therapy of Major OrgansSeminars in Radiation Oncology, 2007
- Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung CancerJournal of Clinical Oncology, 2006
- Three A's of repopulation during fractionated irradiation of squamous epithelia: Asymmetry loss, Acceleration of stem-cell divisions and Abortive divisionsInternational Journal of Radiation Biology, 1997
- Direct Estimation of Latent Time for Radiation Injury in Late-responding Normal Tissues: Gut, Lung, and Spinal CordInternational Journal of Radiation Biology, 1989
- Radiation-induced Peripheral NeuropathyBMJ, 1966